Magee Equation 3 demonstrates predictive and prognostic value for neoadjuvant chemotherapy outcomes in estrogen receptor–positive, human epidermal growth factor receptor 2–negative breast cancer
The ME3 score is predictive of response to neoadjuvant chemotherapy and is prognostically informative, particularly for RCB-3 cases.
Authors
- Julia Foldi (ORCID: https://orcid.org/0000-0002-7504-867X)
- Lakshmi Harinath (ORCID: https://orcid.org/0000-0001-6472-732X)
- A Brufsky
- Jeffrey L. Fine (ORCID: https://orcid.org/0000-0002-2678-8014)
- Olga Navolotskaia
- Beth Z. Clark (ORCID: https://orcid.org/0000-0001-5965-8294)
- Charles E. Geyer (ORCID: https://orcid.org/0000-0002-2379-5702)
- Tatiana Villatoro
- Marija Balić (ORCID: https://orcid.org/0000-0001-9482-9191)
- R A Vanderschelden
- Samaneh Motanagh
- Jing Yu
- Rohit Bhargava
Institutions
- University of Pittsburgh (US)
- Magee-Womens Hospital (US)
- University of Pittsburgh Medical Center (US)
Publication Details
- Journal
- American Journal of Clinical Pathology
- Published
- 2026-01-03
- DOI
- https://doi.org/10.1093/ajcp/aqag001
- Primary Topic
- Breast Cancer Treatment Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00